Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 200 mg
SSGJ-613-AG-III-01
Phase 3 small_molecule active
Quick answer
Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 200 mg for Acute Gout is a Phase 3 program (small_molecule) at Sunshine Biopharma with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Acute Gout
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active